SEC Stock Data Quick Answer Allot Ltd. reported Stockholders Equity of $113.35 million for fiscal year 2025. Allot Ltd. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $113.35M +127.6% 2024 $49.81M +0.1% 2023 $49.76M -51.2% 2022 $101.97M -19.1% 2021 $126.01M -3.2% 2020 $130.15M -1.3% 2019 $131.85M -3.0% 2018 $135.90M -5.0% 2017 $143.13M -9.0% 2016 … Read more
Quick Answer Allot Ltd. reported Cash and Equivalents of $17.11 million for fiscal year 2025. Allot Ltd. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $17.11M +6.0% 2024 $16.14M +13.7% 2023 $14.19M +15.4% 2022 $12.29M +4.9% 2021 $11.72M -50.3% 2020 $23.60M +39.4% 2019 $16.93M +3.6% 2018 $16.34M +6.5% 2017 … Read more
Quick Answer Allot Ltd. reported Total Assets of $172.70 million for fiscal year 2025. Allot Ltd. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $172.70M +23.7% 2024 $139.64M +1.1% 2023 $138.16M -35.1% 2022 $212.95M +4.7% 2021 $203.41M +0.9% 2020 $201.60M -6.3% 2019 $215.17M +13.3% 2018 $189.84M +2.9% 2017 $184.53M -3.4% 2016 … Read more
Quick Answer Allot Ltd. reported Diluted EPS of $0.08 per share for fiscal year 2025. Allot Ltd. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $0.08 +153.3% 2024 -$0.15 +91.0% 2023 -$1.66 -90.8% 2022 -$0.87 -107.1% 2021 -$0.42 -55.6% 2020 -$0.27 -35.0% 2013 -$0.20 +4.8% 2012 -$0.21 -163.6% 2011 $0.33 +232.0% … Read more
Quick Answer Allot Ltd. reported Net Income of $3.71 million for fiscal year 2025. Allot Ltd. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $3.71M +163.1% 2024 -$5.87M +90.7% 2023 -$62.80M -96.1% 2022 -$32.03M -113.0% 2021 -$15.04M -60.9% 2020 -$9.35M -8.0% 2019 -$8.66M +16.9% 2018 -$10.41M +42.4% 2017 -$18.07M -126.1% 2016 … Read more
Quick Answer Allot Ltd. reported Total Revenue of $101.99 million for fiscal year 2025. Allot Ltd. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $101.99M +10.6% 2024 $92.19M -1.0% 2023 $93.15M -24.1% 2022 $122.74M -15.7% 2021 $145.60M +7.1% 2020 $135.92M +23.5% 2019 $110.10M +14.9% 2018 $95.84M +16.9% 2017 $81.99M -9.3% 2016 … Read more
Quick Answer Allot Ltd. reported Total Revenue of $101.99 million for fiscal year 2025. Allot Ltd. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $101.99M+10.6% $92.19M-1.0% $93.15M-24.1% $122.74M-15.7% $145.60M+7.1% $135.92M+23.5% Net Income $3.71M+163.1% -$5.87M+90.7% -$62.80M-96.1% -$32.03M-113.0% -$15.04M-60.9% -$9.35M-8.0% Diluted EPS $0.08+153.3% -$0.15+91.0% -$1.66-90.8% -$0.87-107.1% -$0.42-55.6% -$0.27 Total Assets $172.70M+23.7% … Read more
Quick Answer Allarity Therapeutics, Inc. reported Shares Outstanding of 16.08 million shares for fiscal year 2025. Allarity Therapeutics, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 16.08M +120.2% 2024 7.30M +74327.2% 2023 9,812 -13.6% 2022 11,356 -99.9% 2021 8.10M +90.4% 2020 4.25M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding … Read more
Quick Answer Allarity Therapeutics, Inc. reported Operating Income of -$12.61 million for fiscal year 2025. Allarity Therapeutics, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$12.61M +53.7% 2024 -$27.24M -59.0% 2023 -$17.13M +50.3% 2022 -$34.46M -29.8% 2021 -$26.56M -219.2% 2020 -$8.32M — Quarterly Operating Income Quarter Ending Operating Income YoY … Read more
Quick Answer Allarity Therapeutics, Inc. reported R&D Expense of $6.60 million for fiscal year 2025. Allarity Therapeutics, Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $6.60M +8.3% 2024 $6.10M -14.2% 2023 $7.10M +2.5% 2022 $6.93M -51.2% 2021 $14.20M +236.6% 2020 $4.22M — Quarterly R&D Expense Quarter Ending R&D Expense YoY … Read more